We are live on ! Find out more
HQY icon

HealthEquity

325 hedge funds and large institutions have $3.92B invested in HealthEquity in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 155 increasing their positions, 84 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

85% more repeat investments, than reductions

Existing positions increased: 155 | Existing positions reduced: 84

8% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 53

0% less funds holding

Funds holding: 326325 (-1)

2.38% less ownership

Funds ownership: 97.84%95.45% (-2.4%)

13% less capital invested

Capital invested by funds: $4.52B → $3.92B (-$602M)

65% less call options, than puts

Call options by funds: $14.2M | Put options by funds: $39.9M

Holders
325
Holders Change
-1
Holders Change %
-0.31%
% of All Funds
7.03%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
57
Increased
155
Reduced
84
Closed
53
Calls
$14.2M
Puts
$39.9M
Net Calls
-$25.8M
Net Calls Change
-$18.4M

HQY Hedge Fund Activity: Q2 2019 in Review

325 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q2 2019, worth a combined $3.92B — down 13% from $4.52B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HQY positions and 53 closed out — a net gain of 4 holders — while 155 added to existing stakes and 84 trimmed.

The largest buyer was Jackson Square Partners, adding an estimated $67M. The largest seller was Morgan Stanley, cutting an estimated $357M.

  • 325 institutional investors held HealthEquity (HQY) as of Q2 2019, down from 326 in Q1 2019.
  • Funds reported $3.92B of HealthEquity stock for Q2 2019, down 13% quarter-over-quarter.
  • 57 funds opened new HealthEquity positions in Q2 2019 and 53 closed out, a net change of +4 holders.
  • The largest HealthEquity buyer in Q2 2019 was Jackson Square Partners, an estimated $67M added.
  • The largest HealthEquity seller in Q2 2019 was Morgan Stanley, an estimated $357M sold.

Based on aggregated 13F filings for Q2 2019.